The Executive Director will lead cross functional groups in the developing and execution clinical studies and will play a key leadership role in clinical development programs for non-melanoma skin cancers including CSCC, BCC, MCC, and angiosarcoma, including being accountable for deliverables of the Replimune pipeline to the Executive Leadership Team. The Executive Director will often take the lead on regulatory interactions.
Reporting to the CMO/VP Clinical Development, the Executive Director will be responsible for designing studies within the Replimune pipeline in both early and late stage whilst overseeing other MD/PhD clinical team members (including clinical scientists). The Executive Director will work closely with colleagues in clinical development, program leadership, biometrics, clinical operations, safety/pharmacovigilance, regulatory, molecular diagnostics, and translational research. The Executive Director will also ensure and define strategy for external stakeholder partnership to build, establish and maintain Replimune as a key and competitive player.
Experience and skill requirement:
Software Powered by iCIMS
www.icims.com